| Literature DB >> 35572767 |
Rui Hou1,2,3, Linhui Gao4,2,3, Jianhui Liu1,2, Zhen Liang1,2, Yongjin J Zhou1,4,2, Lihua Zhang1,2, Yukui Zhang1,2.
Abstract
The methylotrophic yeast Pichia pastoris (syn. Komagataella phaffii) has been extensively engineered for protein production, and is attracting attention as a chassis cell for methanol biotransformation toward production of small molecules. However, the relatively unclear methanol metabolism hampers the metabolic rewiring to improve the biosynthetic efficiency. We here performed a label-free quantitative proteomic analysis of Pichia pastoris when cultivated in minimal media containing methanol and glucose, respectively. There were 243, 158 up-regulated proteins and 244, 304 down-regulated proteins in log and stationary phase, respectively, when cultivated in methanol medium compared with that of glucose medium. Peroxisome enrichment further improved the characterization of more differentially expressed proteins (481 proteins in log phase and 524 proteins in stationary phase). We demonstrated the transaldolase isoenzyme (Tal2, Protein ID: C4R244) was highly up-regulated in methanol medium cultivation, which plays an important role in methanol utilization. Our work provides important information for understanding methanol metabolism in methyltrophic yeast and will help to engineer methanol biotransformation in P. pastoris.Entities:
Keywords: Methanol metabolism; Peroxisome; Proteomics; Systems biology
Year: 2022 PMID: 35572767 PMCID: PMC9077519 DOI: 10.1016/j.synbio.2022.04.005
Source DB: PubMed Journal: Synth Syst Biotechnol ISSN: 2405-805X
Strains used in this study.
| Name | Genotype | Resource |
|---|---|---|
| GS115 | Mut+, | Lab stock |
| PC111 | Mut+, | [ |
| TA02 | Mut+, | This study |
Fig. 1Label-free quantitative proteomic analysis of P. pastoris. (A) The growth profiles of P. pastoris GS115 that cultivated in glucose (10 g/L) or methanol (10 g/L) medium and the sample taken time points were indicated as arrows. (B) The workflow for sample preparation. Whole cellular proteome was quantified and the peroxisomes were enriched for proteomic analysis.
Fig. 2Proteomic analysis on Methanol/glucose of whole cell lysate of P. pastoris in log and stationary phase, respectively. Each experimental condition was independently repeated three times and in each of these three biological repetitions, three technical replicas were made. (A) Overlap of identified proteins from three biological repetitions, which are the proteome obtained from the cells that cultured in methanol or glucose. (B) Volcanic maps for differentially expressing proteins. Log-transformed P value (Student's T-test, Benjamini-Hochberg corrected P value: < 0.05) are plotted against log-transform fold change. Red dots (log2FC > 1), significantly upregulation. Blue dots (log2FC < −1), significantly downregulation. Gray dots, non-differentially expressed proteins. Aox1, methanol oxidase 1 (uniprot: P04842), Aox2, methanol oxidase 2 (C4R702) and Das2, dihydroxyacetone synthase 2(C4R5Q0) were dramatically higher up-regulated in log phase than in stationary phase. (C) GO enrichment analysis represented in bubble diagram, including the biological processes (BP), cellular components (CC), and molecular functions (MF). The left and right column charts represent GO enrichment in log phase and in stationary phase, respectively. Only significantly enriched proteins (Modified Fisher Exact test; Benjamini-Hochberg corrected P value: < 0.05) are shown.
Fig. 3Comparing the expression of protein related to central metabolism of P. pastoris that cultivated on methanol or glucose media. The heat map shows the protein expression level of methanol cultured cells compared with glucose cultured cells. Statistical analysis was performed using Student's T-test (Benjamini-Hochberg corrected P value: < 0.05). Red lanes (log2FC > 1), significantly upregulation. Green lanes (log2FC < −1), significantly downregulation. Gray lanes, nondifferentially expressed proteins. Methanol metabolism: Aox1, methanol oxidase 1 (uniprot: P04842; EC: 1.1.3.13); Aox2, methanol oxidase 2 (C4R702; 1.1.3.13); Cat, catalase (C4R2S1; 1.11.1.6); Das1, dihydroxyacetone synthase 1(C4R5P8; 2.2.1.3); Das2, dihydroxyacetone synthase 2(C4R5Q0; 2.2.1.3); Dak, dihydroxyacetone kinase (C4R5Q6; 2.7.1.29); Fba2, fructose 1,6-bisphosphate aldolase (C4QWS2; 4.1.2.13); Fbp1, fructose-bisphosphates (C4R5T8; 3.1.3.11); Shb17, sedoheptulose 1,7-bisphosphatase (C4R2M0; 3.1.3.37); Tal2, transaldolase 2 (C4R244; 2.2.1.2); Gst, glutathione transferase (C4R2T6; 2.5.1.18); Gsr, glutathione reductase (C4R686; 1.8.1.7); Fld, S-hydroxymethyl dehydrogenase (C4R6A5; 1.1.1.284); Fgh, S-formyl glutathione hydrolase (C4R5T5; 3.1.2.12); Fdh, formate dehydrogenase (C4R606; 1.17.1.9); RpiA1-2, d-ribose-5-phosphate ketol-isomerase (C4R763; 5.3.1.6). Pentose phosphate pathway (PPP): Zwf1, glucose-6-phosphate 1-dehydrogenase (C4R099; 1.1.1.49); Pgl, 6-phosphogluconolactonase (C4QWM6; 3.1.1.31); Gnd1, 6-phosphogluconate dehydrogenase (C4R430; 1.1.1.343); Tkl, transketolase (C4QXK7; 2.2.1.1); Tal1, transaldolase 1 (C4R245; 2.2.1.2); RpiA, d-ribose-5-phosphate ketol-isomerase (C4R764; 5.3.1.6); Rpe, ribulose-5-phosphate-3-epimerase (AOA69352; 5.1.3.1). Glycolysis/gluconeogenesis pathway: Hkx, phosphotransferase (C4R8F9; 2.7.1.1); Pgi1, glucose-6-phosphate isomerase (C4R4L7; 5.3.1.9); Fbp1, fructose-bisphosphatase (C4R5T8; 3.1.3.11); Pfk, 6-phosphofructokinase (C4QXA5, Q92448; 2.7.1.11); Fba1, fructose-bisphosphate aldolase (C4QW09; 4.1.2.13); Tpi, triosephosphate isomerase(C4R626; 5.3.1.1); Gapdh, glyceraldehydes-3-phosphate dehydrogenase(C4R0P1; 1.2.1.12); Pgk, phosphoglycerate kinase(C4QY07; 2.7.2.3); Pgam, phosphoglycerate mutase(C4R5A6, C4R5P4; 5.4.2.11); Eno, enolase(C4R3H8; 4.2.1.11); Pyk, pyruvate kinase(C4R1P9; 2.7.1.40); Pck1, phosphoenolpyruvate carboxykinase (C4QZB8; 4.1.1.49); Pyc, pyruvate carboxylase (C4R339; 6.4.1.1). Tricarboxylic acid cycle (TCA): Pdh1, dihydrolipoyllysine-residue acetyltransferase (C4QVY5; 2.3.1.12); Pdh2, pyruvate dehydrogenase (acetyl-transferring) (C4QYX8; 1.2.4.1); Dld, dihydrolipoyl dehydrogenase (C4R312; 1.8.1.4); Cs, citrate synthase (C4QW60; 2.3.3.1); Aco, aconitate hydratase (C4QV90; 4.2.1.3); Idh, isocitrate dehydrogenase (NAD+) (C4QZQ0, C4R8B4; 1.1.1.41); Idh, isocitrate dehydrogenase (NADP+) (C4QWH9, C4R142; 1.1.1.42); Ogdh, oxoglutarate dehydrogenase (succinyl-transferring) (C4QZL6; 1.2.4.2); Dlst, dihydrolipoyllysine-residue succinyltransferase (C4QV80; 2.3.1.61); Scs, succinate—CoA ligase (C4R1X8, C4R5P6; 6.2.1.4); Sdh, succinate dehydrogenase (quinone) (C4R8S1, C4R6J2; 1.3.5.1); Fhd, fumarate hydratase (C4R559; 4.2.1.2); Mdh1, malate dehydrogenase 1 (C4R024; 1.1.1.37); Acs, acetate-CoA ligase (C4R1P7,C4R4G6; 6.2.1.1); Glyoxylic acid cycle: Mdh2, malate dehydrogenase 2 (C4R911; 1.1.1.37); Mls, malate synthase (C4QYI8, C4R741; 2.3.3.9); Icl, isocitrate lyase (C4QY57; 4.1.3.1).
Fig. 4Enriching peroxisomes for comparative proteomics analysis. Statistical analysis was performed using Student's T-test (Benjamini-Hochberg corrected P value: < 0.05). (A) The catalase activity of the whole lysate and the peroxisome enriched fraction. (B) The enzyme activity ratio of catalase/cytochrome c oxidase showed that the peroxisome was enriched and also partially purified from mitochondria. (C) The enzyme up-regulation fold of whole cell lysate and enriched peroxisome fraction.
Fig. 5TAL2 deletion retarded cell growth in methanol medium. Cell growth of wild-type strain and tal2Δ strain in glucose (A) or methanol medium (B). The cells were cultivated in Delft minimal medium containing 10 g/L glucose or methanol at 30 °C, 220 rpm. (C) The proposed Xu-5-P cycle for methanol utilization.